With the project passing Coeur's due diligence it has probably removed any doubts about its merits. Have you thought that other potential bidders might have decided to wait for the results of Coeur's due diligence on it?
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025